Publications

Search or filter publications

Search publications Search

Filter by type:

Filter by publication type

• Book
• Book chapter
• Conference paper
• Journal article
• Other
• Patent
• Poster
• Report
• Scholarly edition
• Software
• Thesis dissertation
• Working paper

Filter by year:

Filter from 2025202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992199119901989198819871986198519841983198219811980 to Filter to 2025202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992199119901989198819871986198519841983198219811980

---

Search results

• Journal article
  Weiss B, Roseman L, Giribaldi B, Nutt DJ, Carhart-Harris RL, Erritzoe Det al., 2024,

  Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder

  , INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION, Vol: 22, Pages: 806-841, ISSN: 1557-1874
  • Cite
• Journal article
  Thurgur H, Lynskey M, Schlag AK, Croser C, Nutt DJ, Iveson Eet al., 2024,

  Feasibility of a cannabidiol-dominant cannabis-based medicinal product for the treatment of long COVID symptoms: A single-arm open-label feasibility trial

  , BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, Vol: 90, Pages: 1081-1093, ISSN: 0306-5251
  • Cite
• Journal article
  Luppi A, Rosas FE, Noonan MP, Mediano PAM, Kringelbach ML, Carhart-Harris RL, Stamatakis EA, Vernon AC, Turkheimer FEet al., 2024,

  Oxygen and the spark of human brain evolution: complex interactions of metabolism and cortical expansion across development and evolution

  , The Neuroscientist, Vol: 30, Pages: 173-198, ISSN: 1073-8584

  Scientific theories on the functioning and dysfunction of the human brain require an understanding of its development—before and after birth and through maturation to adulthood—and its evolution. Here we bring together several accounts of human brain evolution by focusing on the central role of oxygen and brain metabolism. We argue that evolutionary expansion of human transmodal association cortices exceeded the capacity of oxygen delivery by the vascular system, which led these brain tissues to rely on nonoxidative glycolysis for additional energy supply. We draw a link between the resulting lower oxygen tension and its effect on cytoarchitecture, which we posit as a key driver of genetic developmental programs for the human brain—favoring lower intracortical myelination and the presence of biosynthetic materials for synapse turnover. Across biological and temporal scales, this protracted capacity for neural plasticity sets the conditions for cognitive flexibility and ongoing learning, supporting complex group dynamics and intergenerational learning that in turn enabled improved nutrition to fuel the metabolic costs of further cortical expansion. Our proposed model delineates explicit mechanistic links among metabolism, molecular and cellular brain heterogeneity, and behavior, which may lead toward a clearer understanding of brain development and its disorders.

  • Abstract
  • Publisher Web Link
  • Cite
• Journal article
  Lynskey MT, Athanasiou-Fragkouli A, Thurgur H, Schlag AK, Nutt DJet al., 2024,

  Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidence

  , BJPSYCH OPEN, Vol: 10, ISSN: 2056-4724
  • Cite
• Journal article
  Kettner H, Roseman L, Gazzaley A, Carhart-Harris R, Pasquini Let al., 2024,

  Improvements in well-being following naturalistic psychedelic use and underlying mechanisms of change in older adults: A prospective cohort study.

  , Res Sq

  Affective symptoms such as anxiety, low mood, and loneliness are prevalent and highly debilitating symptoms among older adults (OA). Serotonergic psychedelics are novel experimental interventions for affective disorders, yet little is known regarding their effects in OA. Using a prospective cohort design, we identified 62 OA (age ≥ 60 years) and 62 matched younger adults (YA) who completed surveys two weeks before, and one day, two weeks, four weeks, and six months after a guided psychedelic group session in a retreat setting. Mixed linear regression analyses revealed significant well-being improvements in OA and YA, amplified in OA with a history of a psychiatric diagnosis. Compared to YA, acute subjective psychedelic effects were attenuated in OA and did not significantly predict well-being changes. However, a psychosocial measure of Communitas emerged as a predictor in OA, suggesting that the relational components in psychedelic group settings may hold particular value for OA.

  • Abstract
  • Author Web Link
  • Cite
• Journal article
  Vohryzek J, Cabral J, Lord L-D, Fernandes HM, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach MLet al., 2024,

  Brain dynamics predictive of response to psilocybin for treatment-resistant depression

  , BRAIN COMMUNICATIONS, Vol: 6
  • Cite
• Journal article
  Godfrey K, Muthukumaraswamy SD, Stinear CM, Hoeh NRet al., 2024,

  Resting-state EEG connectivity recorded before and after rTMS treatment in patients with treatment-resistant depression

  , PSYCHIATRY RESEARCH-NEUROIMAGING, Vol: 338, ISSN: 0925-4927
  • Cite
• Journal article
  Marrocu A, Kettner H, Weiss B, Zeifman RJ, Erritzoe D, Carhart-Harris RLet al., 2024,

  Psychiatric risks for worsened mental health after psychedelic use

  , JOURNAL OF PSYCHOPHARMACOLOGY, Vol: 38, Pages: 225-235, ISSN: 0269-8811
  • Cite
• Journal article
  Kusudo K, Tani H, Yonezawa K, Nakajima S, Nour MM, Carhart-Harris R, Uchida Het al., 2024,

  Development of the Japanese version of the Ego-Dissolution Inventory (EDI).

  , Neuropsychopharmacol Rep, Vol: 44, Pages: 292-297

  AIM: Psychedelics have recently gained attention as potential therapeutic agents for various psychiatric disorders. Previous research has highlighted that a diminished sense of self, commonly termed "ego-dissolution" is a pivotal feature of the psychedelic-induced state. While the Ego-Dissolution Inventory (EDI) is a widely acknowledged instrument for measuring this phenomenon, no Japanese version has been available. This study aimed to develop a Japanese version of the EDI. METHODS: We adhered to the "Guidelines for Best Practices in the Translation and Cultural Modification Process for Patient-Reported Outcomes Instruments: Document from the ISPOR Committee on Translation and Cultural Modification" during our translation approach. Two Japanese psychiatrists independently conducted initial translations, and a consolidated version was achieved via mutual agreement. This version was then back-translated to English and assessed by the original authors for consistency. The repetitive modification process was conducted in continuous dialogues with the original authors until they accepted the concluding back-translated version. RESULTS: The finalized, approved back-translated version of the EDI is presented in the accompanying figure. In addition, the authorized Japanese version of the EDI is included in the Appendix. CONCLUSIONS: In this study, we successfully developed the Japanese version of the EDI. This instrument will assist in assessing ego-dissolution experiences associated with psychedelic-assisted therapy among Japanese speakers. Additional studies are necessary to evaluate the reliability and validity of this newly translated instrument.

  • Abstract
  • Author Web Link
  • Cite
• Journal article
  Palmisano VF, Agnorelli C, Fagiolini A, Erritzoe D, Nutt D, Faraji S, Nogueira JJet al., 2024,

  Membrane Permeation of Psychedelic Tryptamines by Dynamic Simulations

  , BIOCHEMISTRY, Vol: 63, Pages: 419-428, ISSN: 0006-2960
  • Cite

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.